Immunology and Microbiology
Circumsporozoite Protein
100%
Plasmodium falciparum
89%
Sporozoite
68%
Monospecific Antibody
59%
Monoclonal Antibody
53%
Vaccine Efficacy
49%
Epitope
43%
RTS,S
39%
Mouse
33%
Plasmodium
30%
Human Monoclonal Antibody
28%
Immune Response
20%
Antibody Response
19%
Vaccination Policy
18%
Plasmodium berghei
14%
Transgenics
12%
Virus-Like Particle
12%
Mouse Model
11%
Amino Terminal Sequence
11%
Toxoplasma gondii
11%
Malaria Control
10%
Toxoplasmosis
9%
Amastigote
9%
Hemozoin
9%
Carboxy Terminal Sequence
8%
T-Helper Cell
8%
Immunoglobulin A
7%
Immunoglobulin G2
6%
Light Chain
6%
Chagas Disease
6%
Developmental Stage
6%
Binding Affinity
6%
Trypanosoma Cruzi
6%
CD4
6%
Parasite Transmission
6%
Human Immunoglobulin
5%
Crystal Structure
5%
Cytokine
5%
Antimalarial Agent
5%
T Cell
5%
Cross-Reactivity
5%
Antigen
5%
Keyphrases
Sporozoite
54%
Circumsporozoite Protein
49%
PfCSP
41%
Monoclonal Antibody
35%
Plasmodium Falciparum
34%
Malaria
32%
Malaria Vaccine
21%
Epitope
21%
Liver
17%
Plasmodium
14%
Plasmodium Berghei
14%
Central Repeats
13%
Antibody Response
12%
Immune Protection
11%
AS01
11%
Challenge Model
11%
Antibody Targeting
11%
Vaccine Target
10%
Repeat Region
9%
Hemozoin
9%
Vaccination
9%
Protein Repeats
9%
Antibody-mediated Protection
9%
Transgenic
9%
Immunization
9%
Pre-erythrocytic Stages
8%
Liver Stage
8%
Malaria Infection
7%
In Vivo Model
7%
In Vivo Protection
7%
Virus-like
7%
Particle-based
7%
Blood Meal
6%
Stage Development
6%
Toxoplasma Gondii (T. gondii)
6%
In Vivo Challenge
6%
Parasitemia
5%
Vaccine Antibodies
5%
IFN Production
5%
High Affinity
5%
Plasmodium Liver Stage
5%
Innate Immune Response
5%
Infectivity
5%
